Loading insider details...
Latest Form 4 (Nov 12, 2026): Grant/Award of 80,000 IRLA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Nov 12, 2026 | IRulya Therapeutics Inc. (IRLA) | Grant/Award | 80,000 | n/a |
| May 28, 2026 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Disposition to Issuer | 10,000 | n/a |
| May 21, 2026 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale | 384 | $1.2K |
| May 14, 2026 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale | 855 | $3.1K |
| Feb 20, 2026 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale | 1,157 | $3.9K |
| Feb 18, 2026 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale | 3,726 | $12.3K |
| Feb 13, 2026 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Grant/Award | 29,982 | n/a |
| Nov 20, 2025 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale | 1,086 | $3.2K |
| Oct 16, 2025 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Sale | 19,841 | $78.6K |
| Sep 9, 2025 | ROCKET PHARMACEUTICALS, INC. (RCKT) | Grant/Award | 40,000 | n/a |